Erythrocyte antioxidant defenses as a potential biomarker of liver mitochondrial status in different oxidative conditions

Biomarkers

Volumn 16, Issue 8, 2011, Pages 670-678

  Valdecantos, M Pilar ^a   Pérez Matute, Patricia ^a,b   Prieto Hontoria, Pedro Luis ^a   Snchez Campayo, Elena ^a   Moreno Aliaga, Mara Jess ^a   Martnez, J Alfredo ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

Author keywords

High fat diet; NASH; Obesity; Oxidative stress; Steatosis

Indexed keywords

GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; MITOCHONDRIAL DNA; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOCTIC ACID; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROCYTE CONCENTRATE; FAT CONTENT; FATTY LIVER; LIPID DIET; LIPID PEROXIDATION; LIVER LEVEL; LIVER MITOCHONDRION; MALE; MITOCHONDRIAL RESPIRATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; RAT; WEIGHT CONTROL;

ANIMALS; BASE SEQUENCE; BIOLOGICAL MARKERS; DNA PRIMERS; ERYTHROCYTES; MALE; MITOCHONDRIA, LIVER; OXIDATIVE STRESS; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION;

ANIMALIA;

EID: 81855199735     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2011.625504     Document Type: Article

References (48)

1. Abdel-Wahab YH, O'Harte FP, Mooney MH, Barnett CR, Flatt PR. (2002). Vitamin C supplementation decreases insulin glycation and improves glucose homeostasis in obese hyperglycemic (ob/ob) mice. Metab Clin Exp 51:514-517. (Pubitemid 34406571)
2. Adams LA, Feldstein AE. (2011). Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis. J Dig Dis 12:10-16.
3. Ballinger SW, Van Houten B, Jin GF, Conklin CA, Godley BF. (1999). Hydrogen peroxide causes signifcant mitochondrial DNA damage in human RPE cells. Exp Eye Res 68:765-772. (Pubitemid 29290796)
4. Brand MD. (2010). Te sites and topology of mitochondrial superoxide production. Exp Gerontol 45:466-472.
5. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME. (2004). Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303:2011-2015. (Pubitemid 38393275)
6. Caito S, Hwang JW, Chung S, Yao H, Sundar IK, Rahman I. (2010). PARP-1 inhibition does not restore oxidant-mediated reduction in SIRT1 activity. Biochem Biophys Res Commun 392:264-270.
7. Cantó C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, Auwerx J. (2009). AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458:1056-1060.
8. Carmiel-Haggai M, Cederbaum AI, Nieto N. (2005). A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J 19:136-138. (Pubitemid 40069943)
9. Cohen JC, Horton JD, Hobbs HH. (2011). Human fatty liver disease: old questions and new insights. Science 332:1519-1523.
10. Copple BL, Jaeschke H, Klaassen CD. (2010). Oxidative stress and the pathogenesis of cholestasis. Semin Liver Dis 30:195-204.
11. Cortez-Pinto H, Camilo ME. (2004). Non-alcoholic fatty liver disease/ non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course. Best Pract Res Clin Gastroenterol 18:1089-1104. (Pubitemid 39517694)
12. Cortopassi GA, Shibata D, Soong NW, Arnheim N. (1992). A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc Natl Acad Sci USA 89:7370-7374.
13. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. (2005). Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115:1343-1351. (Pubitemid 40629054)
14. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y Nakayama O, Makishima M, Matsuda M, Shimomura I. (2004). Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114:1752-1761. (Pubitemid 40385531)
15. Gambino R, Musso G, Cassader M. (2011). Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities. Antioxid Redox Signal 15:1325-1365.
16. Kalahasthi RB, Hirehal Raghavendra Rao R, Bagalur Krishna Murthy R. (2006). Plasma lipid peroxidation and erythrocyte antioxidants status in workers exposed to nickel. Biomarkers 11:241-249. (Pubitemid 43879070)
17. Kimura Y Goto Y, Kimura H. (2010). Hydrogen sulfde increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid Redox Signal 12:1-13.
18. Krawczyk M, Bonfrate L, Portincasa P. (2010). Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 24:695-708.
19. Lewis JR, Mohanty SR. (2010). Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 55:560-578.
20. Ljubuncic P, Tanne Z, Bomzon A. (2000). Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease. Gut 47:710-716.
21. Lowes DA, Galley HF. (2011). Mitochondrial protection by the thioredoxin-2 and glutathione systems in an in vitro endothelial model of sepsis. Biochem J 436:123-132.
22. Madsen-Bouterse SA, Zhong Q, Mohammad G, Ho YS, Kowluru RA. (2010). Oxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutase. Free Radic Res 44:313-321.
23. Maritim AC, Sanders RA, Watkins JB 3rd. (2003). Efects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J Nutr Biochem 14:288-294. (Pubitemid 36794267)
24. Michikawa Y, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G. (1999). Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 286:774-779.
25. Millonig G, Praun S, Netzer M, Baumgartner C, Dornauer A, Mueller S, Villinger J, Vogel W. (2010). Non-invasive diagnosis of liver diseases by breath analysis using an optimized ion-molecule reaction-mass spectrometry approach: a pilot study. Biomarkers 15:297-306.
26. Monari M, Trinchero A, Calabrese C, Cattani O, Serrazanetti GP, Foschi J, Fabbri A, Zahlane D, Di Febo G, Tonini V Cervellera M, Tosi MR, Tugnoli V (2006). Superoxide dismutase in gastric adenocarcinoma: is it a clinical biomarker in the development of cancer? Biomarkers 11:574-584. (Pubitemid 44614828)
27. Muyderman H, Wadey AL, Nilsson M, Sims NR. (2007). Mitochondrial glutathione protects against cell death induced by oxidative and nitrative stress in astrocytes. J Neurochem 102:1369-1382. (Pubitemid 47174244)
28. Ozden O, Park SH, Kim HS, Jiang H, Coleman MC, Spitz DR, Gius D. (2011). Acetylation of MnSOD directs enzymatic activity responding to cellular nutrient status or oxidative stress. Aging (Albany NY) 3:102-107.
29. Park HJ, DiNatale DA, Chung MY, Park YK, Lee JY, Koo SI, O'Connor M, Manautou JE, Bruno RS. (2011). Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice. J Nutr Biochem 22:393-400.
30. Pavão ML, Figueiredo T, Santos V Lopes PA, Ferin R, Santos MC, Nève J, Viegas-Crespo AM. (2006). Whole blood glutathione peroxidase and erythrocyte superoxide dismutase activities, serum trace elements (Se, Cu, Zn) and cardiovascular risk factors in subjects from the city of Ponta Delgada, Island of San Miguel, Te Azores Archipelago, Portugal. Biomarkers 11:460-471. (Pubitemid 44364084)
31. Pérez-Carreras M, Del Hoyo P, Martín MA, Rubio JC, Martín A, Castellano G, Colina F, Arenas J, Solis-Herruzo JA. (2003). Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38:999-1007. (Pubitemid 37221683)
32. Pérez-Echarri N, Pérez-Matute P, Marcos-Gómez B, Marti A, Martínez JA, Moreno-Aliaga MJ. (2009). Down-regulation in muscle and liver lipogenic genes: EPA ethyl ester treatment in lean and overweight (high-fat-fed) rats. J Nutr Biochem 20:705-714.
33. Pessayre D. (2007). Role of mitochondria in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 22 Suppl 1:S20-S27. (Pubitemid 46848985)
34. Powell EE, Jonsson JR, Clouston AD. (2010). Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases. Dig Dis 28:186-191.
35. Prieto-Hontoria PL, Pérez-Matute P, Fernández-Galilea M, Barber A, Martínez JA, Moreno-Aliaga MJ. (2009). Lipoic acid prevents body weight gain induced by a high fat diet in rats: efects on intestinal sugar transport. J Physiol Biochem 65:43-50.
36. Rector RS, Tyfault JP, Uptergrove GM, Morris EM, Naples SP, Borengasser SJ, Mikus CR, Laye MJ, Laughlin MH, Booth FW, Ibdah JA. (2010). Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol 52:727-736.
37. Rickwood D, Darley-Usmar VM,Wilson MT. (1987). Mitochondria a practical approach. Oxford, England: IRL Press Oxford.
38. Rohan TE, Wong LJ, Wang T, Haines J, Kabat GC. (2010). Do alterations in mitochondrial DNA play a role in breast carcinogenesis? J Oncol 2010:604304.
39. Rombouts K, Marra F. (2010). Molecular mechanisms of hepatic fbrosis in non-alcoholic steatohepatitis. Dig Dis 28:229-235.
40. Sadi G, Yilmaz O, Güray T. (2008). Efect of vitamin C and lipoic acid on streptozotocin-induced diabetes gene expression: mRNA and protein expressions of Cu-Zn SOD and catalase. Mol Cell Biochem 309:109-116.
41. Simula MP, De Re V. (2010). Hepatitis C virus-induced oxidative stress and mitochondrial dysfunction: a focus on recent advances in proteomics. Proteomics Clin Appl 4:782-793.
42. Solga SF, Alkhuraishe A, Cope K, Tabesh A, Clark JM, Torbenson M, Schwartz P, Magnuson T, Diehl AM, Risby TH. (2006). Breath biomarkers and non-alcoholic fatty liver disease: preliminary observations. Biomarkers 11:174-183. (Pubitemid 43772014)
43. Torsdottir G, Kristinsson J, Snaedal J, Sveinbjörnsdóttir S, Gudmundsson G, Hreidarsson S, Jóhannesson T. (2010). Case-control studies on ceruloplasmin and superoxide dismutase (SOD1) in neurodegenerative diseases: a short review. J Neurol Sci 299:51-54.
44. Valdecantos MP, Pérez-Matute P, Martínez JA. (2009). [Obesity and oxidative stress: role of antioxidant supplementation]. Rev Invest Clin 61:127-139.
45. Valdecantos MP, Pérez-Matute P, Quintero P, Martínez JA. (2010). Vitamin C, resveratrol and lipoic acid actions on isolated rat liver mitochondria: all antioxidants but diferent. Redox Rep 15:207-216.
46. Vincent HK, Taylor AG. (2006). Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond) 30:400-418.
47. Wollin SD, Wang Y, Kubow S, Jones PJ. (2004). Efects of a medium chain triglyceride oil mixture and alpha-lipoic acid diet on body composition, antioxidant status, and plasma lipid levels in the Golden Syrian hamster. J Nutr Biochem 15:402-410. (Pubitemid 38829530)
48. Wree A, Kahraman A, Gerken G, Canbay A. (2011). Obesity afects the liver - the link between adipocytes and hepatocytes. Digestion 83:124-133.